Log In
BCIQ
Print this Print this
 

miRview squamous

Also known as: ProOnc SquamousDx

  Manage Alerts
Collapse Summary General Information
Company Rosetta Genomics Ltd.
DescriptionMicroRNA-based test that measures expression of hsa-miR-205, hsa-mIR-21 and U6 small RNA in tumor tissue
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDifferentiate between squamous and non-squamous non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$8.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/20/2009

Undisclosed

$8.0M

Undisclosed

Get a free BioCentury trial today